Search

Leading Medical Organizations Join Forces Globally to Launch First-Ever World Thrombosis Day

Mar 26 2014 Posted in Press releases

“We must reduce the burden from thrombosis if we are to achieve the World Health Assembly’s global target of reducing mortality from premature non-communicable disease by 25 percent by 2025,” said Gary Raskob, Ph. D.

EHA24 is YOUR congress – here’s how you can make the most of it

May 29 2019

Congress season is an exciting time for any field. It’s a time when experts come together to share the latest developments, and also an opportunity to see friends and colleagues who you haven’t seen in a while.

EBAH CME policy

Welcome to the EBAH CME Accreditation policy for EHA2025 Congress. Below you will find an overview of the EBAH CME credits that can be collected for physical attendance as well as virtual attendance of the sessions.

Apply to be a Master Class mentor

Applications closed on July 15, 2024. There are two types of Master Class mentor: junior mentor and senior mentor. Before you apply, make sure you've read and understood the relevant eligibility criteria.

Treatment, medicine and hematology research: What patients want and doctors need (to know)

Mar 25 2014 Posted in Press releases

Jan Geissler, a Patient Advocate remarked about the Congress: “Over and above scientific updates, much can be achieved in partnership between hematologists and patients.

EHA Statement on COVID-19

The European Hematology Association (EHA) closely monitors the latest developments on the spreading of the Coronavirus (COVID-19).

Stem Cells Journal Club

Join us for engaging, relatable, and memorable discussions about scientific findings. What is the Stem Cells Journal Club?The Stem Cells Journal Club is a way to get the 'inside scoop' on the development of some inspirational hematology papers.

Hematology 2.0: navigating the world of medical apps

Apr 23 2021

Interview with Dr Alex Langridge, SpR, by Dr Nuno Borges, MBBS, MRes, on behalf of YoungEHA. Despite the controversy surrounding them, medical apps remain extremely popular and lucrative endeavors.

The root of evil: pre-leukemic clones that survive chemotherapy are linked to a higher risk of leukemia recurrence

Jun 10 2016 Posted in Press releases

Acute myeloid leukemia (AML) is an aggressive form of blood cancer. Treatment with intensive chemotherapy often leads to a period of freedom from overt disease called a remission. However, recurrence of the disease is common.